title: Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease.
abstract: The National Strategic Framework for Renal Services introduced the routine reporting of estimated glomerular filtration rates (eGFR) on serum urea and electrolyte tests. Estimated glomerular filtration rates might reduce renal failure induced by lithium and cardiovascular mortality but there are many false positives. We propose how eGFR might be used in lithium monitoring.
authors.forename: Richard
authors.initials: R
authors.lastname: Morriss
authors.forename: Benson
authors.initials: B
authors.lastname: Benjamin
mesh_terms: D000367:Age Factors; D000928:Antidepressive Agents / Q000009:adverse effects; D018692:Antimanic Agents / Q000009:adverse effects; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000517:prevention & control*; D007677:Kidney Function Tests / Q000379:methods*; D018020:Lithium Compounds / Q000009:adverse effects*
chemical_list: D000928:Antidepressive Agents; D018692:Antimanic Agents; D018020:Lithium Compounds; D003404:Creatinine